Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism α7 receptor agonists(Neuronal acetylcholine receptor protein alpha-7 subunit agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H17N3O2 |
InChIKeyPTGWFYYEAUFEAS-ZYHUDNBSSA-N |
CAS Registry508202-22-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Preclinical | US | 15 Jun 2008 |